Statins beneficial as primary CVD prevention in older adults, study suggests

Statins were associated with a reduced risk for CVD and death in older adults, even those aged 85 years and older, data in Annals of Internal Medicine showed.
Researchers said the findings support the use of statin therapy as primary CVD prevention in this population.
In August, the U.S. Preventive Services Task Force said there is insufficient evidence to assess the benefits and harms of starting statin therapy in adults aged 76 years and older for primary prevention of CVD and mortality.
Previous studies on the potential benefits of statin therapy are limited by an underrepresentation of older

Statins were associated with a reduced risk for CVD and death in older adults, even those aged 85 years and older, data in Annals of Internal Medicine showed.
Researchers said the findings support the use of statin therapy as primary CVD prevention in this population.
In August, the U.S. Preventive Services Task Force said there is insufficient evidence to assess the benefits and harms of starting statin therapy in adults aged 76 years and older for primary prevention of CVD and mortality.
Previous studies on the potential benefits of statin therapy are limited by an underrepresentation of older